CCS
CC icon

Crosspoint Capital Strategies’s Chemours CC Stock Holding History

Crosspoint Capital Strategies’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-60
Closed – – 210
2015
Q4 		$0 Sell
60
-120
-67% -$767 ﹤0.01% 1020
2015
Q3 		$1K Buy
+180
New +$1.88K ﹤0.01% 661

Other funds holding CC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CCM
Conatus Capital Management Greenwich, Connecticut $92.3M AUM 45.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Crosspoint Capital Strategies's CC Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Chemours (CC) in Q1 2016, closing a stake of 60 shares.

Crosspoint Capital Strategies first reported a position in CC in Q3 2015 and held it in 2 quarters. The position peaked at $1K in Q3 2015. 415 funds tracked by Wall St. Rank hold CC as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Chemours position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 60 Chemours shares in Q1 2016.
  • Crosspoint Capital Strategies first reported a position in Chemours in Q3 2015 and held it in 2 quarters.
  • Crosspoint Capital Strategies's Chemours position peaked at $1K in Q3 2015.
  • 415 funds tracked by Wall St. Rank held Chemours as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.